In clinical studies, a connection has been established between hypertrophic cardiomyopathy and mutations found in the NDUFS2 and NDUFV2 genes in patients undergoing clinic‐treatment.36 Here, NDUFS2 is linked to hypertrophic cardiomyopathy.